• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白E通过激活免疫功能抑制胶质瘤进展。

ApoE Inhibits the Progression of Glioma by Activating Immune Function.

作者信息

Liu Xiao-Fei, Chang Yu-Jie, Long Min, Huang Kai-Qi, Wang Bing, Gong Duo, Luo Jun-Li, Feng Yong

机构信息

Hengyang Medical School, University of South China, Hengyang, Hunan, China.

Department of Neurosurgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.

出版信息

J Cell Mol Med. 2025 Jul;29(13):e70697. doi: 10.1111/jcmm.70697.

DOI:10.1111/jcmm.70697
PMID:40662483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12261038/
Abstract

Glioma, marked by a low mutational burden, low immunogenicity, high heterogeneity, and the challenges posed by the blood-brain barrier, continues to be a major hurdle in neuro-oncology. Current research underscores the necessity for more effective medications and treatment strategies. In this study, we explored the role of Apolipoprotein E (ApoE) in glioma using both bioinformatics and experimental methods. The construction of our bioinformatics risk model identified ApoE as a protective factor linked to longer survival in glioma patients. Subsequently, we created an in situ tumorigenic mouse model and a subcutaneous tumorigenic mouse model with ApoE gene knockout to evaluate the functional impacts of ApoE deficiency in glioma. Our results demonstrated that ApoE deficiency accelerates the growth of glioma and encourages the invasive behaviour of tumour cells into normal brain tissue. Additionally, we detected a reduction in the immune surveillance of glioma in the context of ApoE deficiency. Furthermore, flow cytometry analysis indicated that the lack of ApoE led to a decrease in positive immune cells and an increase in immunosuppressive cells within the tumour microenvironment. Our findings suggest that ApoE plays a crucial role in modulating glioma progression and immune surveillance, highlighting its potential as a therapeutic target.

摘要

胶质瘤具有低突变负荷、低免疫原性、高异质性以及血脑屏障带来的挑战,仍然是神经肿瘤学中的一个主要障碍。当前的研究强调了更有效药物和治疗策略的必要性。在本研究中,我们使用生物信息学和实验方法探索了载脂蛋白E(ApoE)在胶质瘤中的作用。我们的生物信息学风险模型构建确定ApoE是与胶质瘤患者更长生存期相关的保护因素。随后,我们创建了ApoE基因敲除的原位致瘤小鼠模型和皮下致瘤小鼠模型,以评估ApoE缺乏在胶质瘤中的功能影响。我们的结果表明,ApoE缺乏会加速胶质瘤的生长,并促进肿瘤细胞向正常脑组织的侵袭行为。此外,我们检测到在ApoE缺乏的情况下胶质瘤的免疫监视降低。此外,流式细胞术分析表明,ApoE的缺乏导致肿瘤微环境中阳性免疫细胞减少和免疫抑制细胞增加。我们的研究结果表明,ApoE在调节胶质瘤进展和免疫监视中起关键作用,突出了其作为治疗靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/aa8a67f1b771/JCMM-29-e70697-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/e245e4aee180/JCMM-29-e70697-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/98f45f73ce80/JCMM-29-e70697-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/8a2fa3edd77b/JCMM-29-e70697-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/d35d24428e2e/JCMM-29-e70697-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/52bb33e882fb/JCMM-29-e70697-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/956daa8ea1d7/JCMM-29-e70697-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/aa8a67f1b771/JCMM-29-e70697-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/e245e4aee180/JCMM-29-e70697-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/98f45f73ce80/JCMM-29-e70697-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/8a2fa3edd77b/JCMM-29-e70697-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/d35d24428e2e/JCMM-29-e70697-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/52bb33e882fb/JCMM-29-e70697-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/956daa8ea1d7/JCMM-29-e70697-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a5d/12261038/aa8a67f1b771/JCMM-29-e70697-g003.jpg

相似文献

1
ApoE Inhibits the Progression of Glioma by Activating Immune Function.载脂蛋白E通过激活免疫功能抑制胶质瘤进展。
J Cell Mol Med. 2025 Jul;29(13):e70697. doi: 10.1111/jcmm.70697.
2
Integrated Transcriptome Profiling and Pan-Cancer Analyses Reveal Oncogenic Networks and Tumor-Immune Modulatory Roles for FABP7 in Brain Cancers.整合转录组谱分析和泛癌分析揭示 FABP7 在脑肿瘤中的致癌网络和肿瘤免疫调节作用。
Int J Mol Sci. 2024 Nov 14;25(22):12231. doi: 10.3390/ijms252212231.
3
Inhibition of NFE2L1 Enables the Tumor-Associated Macrophage Polarization and Enhances Anti-PD1 Immunotherapy in Glioma.抑制NFE2L1可促进肿瘤相关巨噬细胞极化并增强胶质瘤的抗PD1免疫治疗。
CNS Neurosci Ther. 2025 Jul;31(7):e70488. doi: 10.1111/cns.70488.
4
High ELK3 expression is associated with the wild type IDH1 in glioma and enhances infiltration of M2 macrophages.ELK3高表达与胶质瘤中的野生型异柠檬酸脱氢酶1(IDH1)相关,并增强M2巨噬细胞的浸润。
Int Immunopharmacol. 2025 Aug 28;161:115064. doi: 10.1016/j.intimp.2025.115064. Epub 2025 Jun 12.
5
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
6
TMEM115: a promising marker for glioma immunotherapy and prognosis.跨膜蛋白115:一种有前景的神经胶质瘤免疫治疗和预后标志物。
Front Immunol. 2025 Jun 9;16:1598499. doi: 10.3389/fimmu.2025.1598499. eCollection 2025.
7
TMEM150A overexpression was associated with poor prognosis and cancer progression in glioma verified by comprehensive analysis and cell experiments.通过综合分析和细胞实验证实,TMEM150A过表达与胶质瘤的不良预后和癌症进展相关。
Sci Rep. 2025 Jul 11;15(1):25017. doi: 10.1038/s41598-025-08752-2.
8
PMN-MDSCs are responsible for immune suppression in anti-PD-1 treated TAP1 defective melanoma.多形核髓系来源抑制细胞(PMN-MDSCs)在抗程序性死亡蛋白1(PD-1)治疗的TAP1缺陷型黑色素瘤中发挥免疫抑制作用。
Clin Transl Oncol. 2025 Jan 18. doi: 10.1007/s12094-024-03840-7.
9
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
10
Radiotherapy for diffuse brainstem glioma in children and young adults.儿童和青年弥漫性脑干胶质瘤的放射治疗
Cochrane Database Syst Rev. 2016 Jun 27;2016(6):CD010439. doi: 10.1002/14651858.CD010439.pub2.

本文引用的文献

1
Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches.革命性的脑胶质瘤治疗方法:现代治疗方法的全面概述。
Int J Mol Sci. 2024 May 26;25(11):5774. doi: 10.3390/ijms25115774.
2
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.CBTRUS 统计报告:美国脑肿瘤协会和 NCI 神经肿瘤学分部 2016-2020 年在美国诊断的青少年和年轻成人原发性脑和其他中枢神经系统肿瘤。
Neuro Oncol. 2024 May 6;26(Supplement_3):iii1-iii53. doi: 10.1093/neuonc/noae047.
3
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity.
放疗重塑肿瘤微环境以增强免疫治疗敏感性。
Cell Death Dis. 2023 Oct 13;14(10):679. doi: 10.1038/s41419-023-06211-2.
4
The cell biology of APOE in the brain.载脂蛋白 E 在大脑中的细胞生物学。
Trends Cell Biol. 2024 Apr;34(4):338-348. doi: 10.1016/j.tcb.2023.09.004. Epub 2023 Oct 5.
5
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.美国 2016-2020 年诊断的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2023 Oct 4;25(12 Suppl 2):iv1-iv99. doi: 10.1093/neuonc/noad149.
6
Immunotherapy: a promising approach for glioma treatment.免疫疗法:胶质母细胞瘤治疗的一种有前途的方法。
Front Immunol. 2023 Sep 7;14:1255611. doi: 10.3389/fimmu.2023.1255611. eCollection 2023.
7
Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment.光学血脑肿瘤屏障调控拓展了胶质母细胞瘤治疗的治疗选择。
Nat Commun. 2023 Aug 15;14(1):4934. doi: 10.1038/s41467-023-40579-1.
8
Anti-glioma effect of ginseng-derived exosomes-like nanoparticles by active blood-brain-barrier penetration and tumor microenvironment modulation.人参衍生的外泌体样纳米颗粒通过主动血脑屏障穿透和肿瘤微环境调节发挥抗神经胶质瘤作用。
J Nanobiotechnology. 2023 Aug 4;21(1):253. doi: 10.1186/s12951-023-02006-x.
9
Comprehensive analysis of the expression and prognosis for APOE in malignancies: A pan-cancer analysis.全面分析 APOE 在恶性肿瘤中的表达和预后:泛癌分析。
Oncol Res. 2022 Dec 6;30(1):13-22. doi: 10.32604/or.2022.026141. eCollection 2022.
10
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial.采用可植入式超声设备反复打开血脑屏障,以递送白蛋白结合型紫杉醇治疗复发性胶质母细胞瘤患者:一项 1 期试验。
Lancet Oncol. 2023 May;24(5):509-522. doi: 10.1016/S1470-2045(23)00112-2.